• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Menopausal Hot Flashes - Pipeline Review, H2 2012 Product Image

Menopausal Hot Flashes - Pipeline Review, H2 2012

  • ID: 2244960
  • September 2012
  • 58 pages
  • Global Markets Direct

Menopausal Hot Flashes – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes. Menopausal Hot Flashes - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Menopausal Hot Flashes.
- A review of the Menopausal Hot Flashes products under development by companies READ MORE >

2
List of Tables 4
List of Figures 5
Introduction 6
REPORT COVERAGE 6
Menopausal Hot Flashes Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Menopausal Hot Flashes 8
Menopausal Hot Flashes Therapeutics under Development by Companies 10
Menopausal Hot Flashes Therapeutics under Investigation by Universities/Institutes 11
Late Stage Products 12
Comparative Analysis 12
Mid Clinical Stage Products 13
Comparative Analysis 13
Menopausal Hot Flashes Therapeutics – Products under Development by Companies 14
Menopausal Hot Flashes Therapeutics – Products under Investigation by Universities/Institutes 15
Companies Involved in Menopausal Hot Flashes Therapeutics Development 16
Eisai Co., Ltd. 16
Bionovo, Inc. 17
PharmaNova Inc. 18
Pherin Pharmaceuticals, Inc. 19
Menopausal Hot Flashes – Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Combination Products 21
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
gabapentin ER - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
gabapentin ER - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
RAD-1901 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
liquiritigenin - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Acupuncture + Gabapentin - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
pregabalin - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
megestrol acetate - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
citalopram hydrobromide - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
progesterone - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
PH-80HF - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
gabapentin - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Menopausal Hot Flashes Therapeutics – Drug Profile Updates 41
Menopausal Hot Flashes Therapeutics – Discontinued Products 48
Menopausal Hot Flashes Therapeutics - Dormant Products 49
Menopausal Hot Flashes – Product Development Milestones 50
Featured News & Press Releases 50
Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women 50
Jul 31, 2012: Depomed Announces Submission Of Serada New Drug Application 50
Apr 17, 2012: Depomed Intends To File NDA For Serada For Treatment Of Menopausal Hot Flashes 51
Mar 28, 2012: Bionovo's Independent Data Safety Monitoring Board Recommends Continuation Of Phase III Study For Menerba 51
Nov 16, 2011: Bionovo To Begin Dosing In Menerba Phase III Clinical Trial For Menopausal Hot Flashes 52
Oct 26, 2011: Bionovo Initiates Menerba Phase III Clinical Trial For Menopausal Hot Flashes 53
Oct 13, 2011: Depomed Announces Top-Line Results From Serada Phase III Trial BREEZE 3 In Menopausal Hot Flashes 53
Aug 30, 2011: Bionovo Announces Positive Results From Tolerability Trial Of Menerba For Menopausal Hot Flashes 54
Jul 25, 2011: Bionovo Announces Successful Completion Of Animal Toxicology Studies For MF101 55
Mar 28, 2011: Bionovo Initiates Enrollment In Menerba Phase I 'Tolerability' Clinical Trial For Menopausal Hot Flushes 55
Appendix 57
Methodology 57
Coverage 57
Secondary Research 57
Primary Research 57
Expert Panel Validation 57
Contact Us 58
Disclaimer 58

List of Tables
Number of Products Under Development for Menopausal Hot Flashes, H2 2012 8
Products under Development for Menopausal Hot Flashes – Comparative Analysis, H2 2012 9
Number of Products under Development by Companies, H2 2012 10
Number of Products under Investigation by Universities/Institutes, H2 2012 11
Comparative Analysis by Late Stage Development, H2 2012 12
Comparative Analysis by Mid Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Products under Investigation by Universities/Institutes, H2 2012 15
Eisai Co., Ltd., H2 2012 16
Bionovo, Inc., H2 2012 17
PharmaNova Inc., H2 2012 18
Pherin Pharmaceuticals, Inc., H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Combination Products, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 25
Menopausal Hot Flashes Therapeutics – Drug Profile Updates 41
Menopausal Hot Flashes Therapeutics – Discontinued Products 48
Menopausal Hot Flashes Therapeutics – Dormant Products 49

List of Figures
Number of Products under Development for Menopausal Hot Flashes, H2 2012 8
Products under Development for Menopausal Hot Flashes – Comparative Analysis, H2 2012 9
Products under Development by Companies, H2 2012 10
Products under Investigation by Universities/Institutes, H2 2012 11
Late Stage Products, H2 2012 12
Mid Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Combination Products, H2 2012 21
Assessment by Route of Administration, H2 2012 22
Assessment by Stage and Route of Administration, H2 2012 23
Assessment by Molecule Type, H2 2012 24
Assessment by Stage and Molecule Type, H2 2012 25

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos